Rallybio Corporation (RLYB) financial statements (2022 and earlier)

Company profile

Business Address 234 CHURCH STREET
NEW HAVEN, CT 06510
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments175,334
Cash and cash equivalents175,334
Other undisclosed current assets5,535
Total current assets:180,869
Noncurrent Assets
Property, plant and equipment511
Long-term investments and receivables805
Long-term investments805
Total noncurrent assets:1,316
TOTAL ASSETS:182,185
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,551
Accounts payable603
Accrued liabilities5,948
Total current liabilities:6,551
Noncurrent Liabilities
Liabilities, other than long-term debt32
Accounts payable and accrued liabilities32
Total noncurrent liabilities:32
Total liabilities:6,583
Stockholders' equity
Stockholders' equity attributable to parent175,602
Common stock3
Additional paid in capital269,626
Accumulated deficit(94,027)
Total stockholders' equity:175,602
TOTAL LIABILITIES AND EQUITY:182,185

Income statement (P&L) ($ in thousands)

12/31/2021
Operating expenses(45,648)
Operating loss:(45,648)
Nonoperating income140
Other nonoperating income96
Interest and debt expense(10)
Loss from continuing operations before equity method investments, income taxes:(45,518)
Other undisclosed income from continuing operations before income taxes10
Loss before gain (loss) on sale of properties:(45,508)
Other undisclosed net loss(1,505)
Net loss available to common stockholders, diluted:(47,013)

Comprehensive Income ($ in thousands)

12/31/2021
Net loss:(47,013)
Comprehensive loss, net of tax, attributable to parent:(47,013)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: